<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39328255</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2205-0140</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Australasian journal of ultrasound in medicine</Title><ISOAbbreviation>Australas J Ultrasound Med</ISOAbbreviation></Journal><ArticleTitle>Assessment of the liver with two-dimensional shear wave elastography following COVID-19 infection: A pilot study.</ArticleTitle><Pagination><StartPage>167</StartPage><EndPage>173</EndPage><MedlinePgn>167-173</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajum.12390</ELocationID><Abstract><AbstractText Label="INTRODUCTION/PURPOSE" NlmCategory="UNASSIGNED">The coronavirus disease (COVID-19) is a widely spread viral infectious disease, which can impact multiple organs, including the liver. Elevated liver enzymes have been reported in COVID-19 patients; however, potential changes in liver stiffness following the viral infection remain uncertain. The main aim of this pilot study was to determine if there is a significant difference in liver stiffness between individuals who have never been infected with COVID-19 and those who had been infected with COVID-19 &lt;6 months, experiencing only mild symptoms. The secondary aim was to compare the liver stiffness between participants infected with COVID-19 depending on the elapsed time since infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Two-dimensional shear wave elastography (2D-SWE) was performed prospectively on 68 participants. Thirty-four participants had been infected with COVID-19 (all for &lt;6 months) (COVID-19 group), and another 34 had never been infected with COVID-19 (control group). The mean 2D-SWE measurements of both the COVID-19 group and the control group were compared using an independent <i>t</i>-test. The mean 2D-SWE measurements of the COVID-19 subgroups A (&lt;2 months), B (2 to &lt;4 months) and C (4 to &lt;6 months) were compared using a one-way ANOVA test (P &lt; 0.05).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The (mean ± standard deviation) liver stiffness (kPa) of the COVID-19 group (5.26 ± 1.63 kPa) was significantly higher than the control group (4.30 ± 0.96 kPa) (P = 0.005). There was no significant difference in liver stiffness among subgroups A (5.20 ± 1.79 kPa), B (4.70 ± 1.53 kPa) and C (5.96 ± 1.48 kPa) (P = 0.143) respectively.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">The mean liver stiffness of 4.30  ±  0.96k Pa in the control group showed a high probability of being normal as per guidelines. Conversely, the mean liver stiffness of 5.26  ±  1.63 kPa in the COVID-19 group exhibited a statistically significant increase compared to the control group. However, compensated advanced chronic liver disease was ruled out without other known clinical signs, as per guidelines.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">A statistically significant increase in liver stiffness value was observed in the post-COVID-19 infection group compared to the group who had never been infected. This highlights the potential for short-term impact on liver stiffness associated with COVID-19 infection. However, it is unclear if these changes in liver stiffness are associated with liver injury. Further study is warranted to investigate the effects of COVID-19 infection and its long-term impact on the liver.</AbstractText><CopyrightInformation>© 2024 The Authors. Australasian Journal of Ultrasound in Medicine published by John Wiley &amp; Sons Australia, Ltd on behalf of Australasian Society for Ultrasound in Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Joyce Yea See</ForeName><Initials>JYS</Initials><Identifier Source="ORCID">0009-0002-6167-3578</Identifier><AffiliationInfo><Affiliation>SKG Radiology Level 3, 1 Hood Street Subiaco 6008 Western Australia Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Imaging and Radiation Sciences Monash University Wellington Rd Clayton 3800 Victoria Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hara</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5995-8032</Identifier><AffiliationInfo><Affiliation>SKG Radiology Level 3, 1 Hood Street Subiaco 6008 Western Australia Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lombardo</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging and Radiation Sciences Monash University Wellington Rd Clayton 3800 Victoria Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodyear</LastName><ForeName>Melinda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Rural Health Monash University Wellington Rd Clayton 3800 Victoria Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Australas J Ultrasound Med</MedlineTA><NlmUniqueID>101583539</NlmUniqueID><ISSNLinking>1836-6864</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">elastography</Keyword><Keyword MajorTopicYN="N">liver</Keyword><Keyword MajorTopicYN="N">liver injury</Keyword><Keyword MajorTopicYN="N">shear wave elastography</Keyword><Keyword MajorTopicYN="N">ultrasound</Keyword></KeywordList><CoiStatement>The authors have no known conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>5</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39328255</ArticleId><ArticleId IdType="pmc">PMC11423436</ArticleId><ArticleId IdType="doi">10.1002/ajum.12390</ArticleId><ArticleId IdType="pii">AJUM12390</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO (World Health Organization) Coronavirus Disease (COVID‐19). https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019. (2022). Accessed 20 Aug 2022.</Citation></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID‐19. Nat Med 2020; 26(7): 1017–1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Feng J, Wan H, Zeng X, Ji P, Zhang J. Liver injury associated with the severity of COVID‐19: a meta‐analysis. Front Public Heath 2023; 11: 1003352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932800</ArticleId><ArticleId IdType="pubmed">36817905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Aghemo A, Forne A, Valenti L. COVID‐19 and liver disease. Liver Int 2020; 40: 1278–1281.</Citation><ArticleIdList><ArticleId IdType="pubmed">32251539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID‐19. Hypertens Res 2020; 43: 648–654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184165</ArticleId><ArticleId IdType="pubmed">32341442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yu Y, Zhang C, et al. Mechanism of SARS‐CoV‐2 invasion into the liver and hepatic injury in patients with COVID‐19. Mediterr J Hematol Infect Dis 2022; 14(1): 32022003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8747016</ArticleId><ArticleId IdType="pubmed">35070210</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo AD, Schneeweiss‐Gleicner M, Bakail M, et al. Pathophysiological mechanisms of liver injury in COVID‐19. Liver Int 2020; 41(1): 20–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753756</ArticleId><ArticleId IdType="pubmed">33190346</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Qian S, Zhang S, Zhang Z. Single‐cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun 2020; 526: 135–140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single‐cell RNA expression profiling of ACE2, the receptor of SARS‐Cov‐2. Am J Respir Crit Care Med 2020; 202: 756–759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462411</ArticleId><ArticleId IdType="pubmed">32663409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kukla M, Skonieczna‐Zydecka K, Kotfis K, et al. COVID‐19, MERS and SARS with concomitant liver injury‐systematic review of the existing literature. J Clin Med 2020; 9(5): 1420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290752</ArticleId><ArticleId IdType="pubmed">32403255</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID‐19 in the new York City area. JAMA 2020; 323: 2052–2059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID‐19: a randomised, double‐blind, placebo‐controlled, multicentre trial. Lancet 2020; 395: 1569–1578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190303</ArticleId><ArticleId IdType="pubmed">32423584</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, et al. Experimental treatment with Favipiravir for COVID‐19: an open‐label control study. Engineering 2020; 6: 1192–1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185795</ArticleId><ArticleId IdType="pubmed">32346491</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID‐19: abnormal liver function tests. J Hepatol 2020; 73: 566–574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194951</ArticleId><ArticleId IdType="pubmed">32298767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhao H, Liu LG, Wang YB, Zhang T, Li MH, et al. Pattern of liver injury in adult patients with COVID‐19: a retrospective analysis of 105 patients. Mil Med Res 2020; 7: 28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276224</ArticleId><ArticleId IdType="pubmed">32507110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, Yang Q, Wang X, Hu W, Lu Y, Yang K, et al. Association between drug treatments and the incidence of liver injury in hospitalized patients with COVID‐19. Front Pharmacol 2022; 13: 799338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8978013</ArticleId><ArticleId IdType="pubmed">35387350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CKH, Au ICH, Cheng WY, Man KKC, Lau KTK, Mak LY, et al. Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID‐19: a self‐controlled case series study. Aliment Pharmacol Ther 2022; 56: 121–130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111503</ArticleId><ArticleId IdType="pubmed">35318694</ArticleId></ArticleIdList></Reference><Reference><Citation>Grein J, Myers RP, Brainard D. Compassionate use of Remdesivir in COVID‐19. N Engl J Med 2020; 382: e101.</Citation><ArticleIdList><ArticleId IdType="pubmed">32412709</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir– ritonavir in adults hospitalized with severe COVID‐19. N Engl J Med 2020; 382: 1787–1799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121492</ArticleId><ArticleId IdType="pubmed">32187464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushner T, Cafardi J. Chronic liver disease and covid‐19: alcohol use disorder/alcohol‐associated liver disease, nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, autoimmune liver disease, and compensated cirrhosis. Clin Liver Dis 2020; 15: 195–199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280613</ArticleId><ArticleId IdType="pubmed">32537135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalic AJ, Satapatphy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID‐19 and their clinical outcomes: a systematic review and meta‐analysis. Hepatol Int 2020; 14: 612–620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386238</ArticleId><ArticleId IdType="pubmed">32725453</ArticleId></ArticleIdList></Reference><Reference><Citation>Frulio N, Trillaud H. Ultrasound elastography in liver. Diagn Interv Imaging 2013; 94: 515–534.</Citation><ArticleIdList><ArticleId IdType="pubmed">23623211</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr RG, Wilson SR, Rubens D, Garcia‐Tsao G, Ferraioli G. Update to the society of radiologists in ultrasound liver elastography consensus statement. Radiology 2020; 296: 263–274.</Citation><ArticleIdList><ArticleId IdType="pubmed">32515681</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiina T, Nightingale KR, Palmeri ML, Hall TJ, Bamber JC, Barr RG, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 1: basic principles and terminology. Ultrasound Med Biol 2015; 41(5): 1126–1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">25805059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei H, Jiang HY, Li M, Zhang T, Song B. Two‐dimensional shear wave elastography for significant liver fibrosis in patients with chronic hepatitis B: a systematic review and meta‐analysis. Eur J Radiol 2020; 124: 108839.</Citation><ArticleIdList><ArticleId IdType="pubmed">31981878</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimoriya R, Piya MK, Simmons D, Ahlenstiel G, Ho V. The use of two‐dimensional shear wave elastography in people with obesity for the assessment of liver fibrosis in non‐alcoholic fatty liver disease. J Clin Med 2020; 10(1): 95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7795317</ArticleId><ArticleId IdType="pubmed">33383965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Guo H, Zeng J, et al. Two‐dimensional shear‐wave elastography and conventional us: the optimal evaluation of liver fibrosis and cirrhosis. Radiology 2015; 275(1): 290–300.</Citation><ArticleIdList><ArticleId IdType="pubmed">25575116</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzina M, Putrins DS, Micena AV, Vanaga I, Kolesova O, Platkajis A, et al. Post COVID‐19 liver injury: comprehensive imaging with multiparametric ultrasound. J Ultrasound Med 2022; 41: 935–949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427044</ArticleId><ArticleId IdType="pubmed">34241914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolesova O, Vanaga I, Laivacuma S. Intriguing findings of liver fibrosis following COVID‐19. BMC Gastroenterol 2021; 21: 370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8503733</ArticleId><ArticleId IdType="pubmed">34635073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraioli G, Filice C, Castera L, Choi BI, Sporea I, Wilson SR, et al. WFUMB guidelines and recommendations of for clinical use of ultrasound elastography: part 3: liver. Ultrasound Med Biol 2015; 41(5): 1161–1179.</Citation><ArticleIdList><ArticleId IdType="pubmed">25800942</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Hara S, Zelesco M, Rocke K, Stevenson G, Sun Z. Reliability indicators for 2‐dimensional shear wave elastography. J Ultrasound Med 2019; 38: 3065–3071.</Citation><ArticleIdList><ArticleId IdType="pubmed">30887548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini M, Megna AS, Ragucci M, et al. Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease. PLoS One 2017; 12(10): e0185391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5638246</ArticleId><ArticleId IdType="pubmed">29023554</ArticleId></ArticleIdList></Reference><Reference><Citation>Moga T, Stepan A, Pienar CM, et al. Intra‐ and inter‐observer reproducibility of a 2‐d shear wave elastography technique and the impact of ultrasound experience in achieving reliable data. Ultrasound Med Biol 2018; 44(8): 1627–1637.</Citation><ArticleIdList><ArticleId IdType="pubmed">29801976</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, Liao M, Zheng J, Huang Z, Xie S. Two‐ dimensional shear wave elastography utilized in patients with ascites: a more reliable method than transient elastography for noninvasively detecting the liver stiffness‐ and original study with 170 patients. Atmosfera 2023; 11(2): 80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9929815</ArticleId><ArticleId IdType="pubmed">36819487</ArticleId></ArticleIdList></Reference><Reference><Citation>Oubek ME, Trautwein C, Strnad P. Reversal of liver fibrosis: from fiction to reality. Best Practice Res Clin Gatroenterol 2017; 31(2): 129–141.</Citation><ArticleIdList><ArticleId IdType="pubmed">28624101</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>